Xerophthalmia
10
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome
Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops
Exosome-miRNA and Transcriptome Profiling of Dry Eye Syndrome and Sjogren's Syndrome
VGH-DESJS-1 in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome and Sjögren's Syndrome
To Evaluate the Short-term and Long Term Efficacy of Acupuncture in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome
Ocular Manifestations in Rheumatic Diseases
Effect of Meibomian Gland Related Therapy on the Morphology of Meibomian Gland
Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population
Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry Eye
Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes